VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,486 hedge funds and large institutions have $97.5B invested in Vertex Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 171 funds opening new positions, 607 increasing their positions, 515 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,486
Holders Change
+54
Holders Change %
+3.77%
% of All Funds
21.54%
Holding in Top 10
30
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-26.83%
% of All Funds
0.43%
New
171
Increased
607
Reduced
515
Closed
96
Calls
$718M
Puts
$774M
Net Calls
-$56.7M
Net Calls Change
+$22.3M

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$1.57B
2
Capital Research Global Investors
Capital Research Global Investors
California
+$910M
3
Jennison Associates
Jennison Associates
New York
+$350M
4
Amundi
Amundi
France
+$341M
5
Norges Bank
Norges Bank
Norway
+$174M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$1.16B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$964M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$583M
4
Winslow Capital Management
Winslow Capital Management
Minnesota
-$387M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$343M
Name Holding Trade Value Shares
Change 		Shares
Change %
LFA
1576
LGT Financial Advisors
Texas
– -$6.51K -16 Closed
MIM
1577
Macroview Investment Management
Maryland
– -$6.51K -16 Closed
AWM
1578
Able Wealth Management
New Jersey
– -$5.7K -14 Closed
TFGT
1579
TS Financial Group (TSFG)
Illinois
– -$5K -12 Closed
TIM
1580
Tortoise Investment Management
New York
– -$2.03K -5 Closed
AIMA
1581
Ables Iannone Moore & Associates
Georgia
– -$1.63K -4 Closed
60 61 62 63
64